{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-015990","form_type":"8-K","ticker":"IRD","cik":"0001228627","company_name":"Opus Genetics, Inc.","filed_at":"2026-04-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.055649+00:00","generated_at":"2026-05-15T04:50:37.116265+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Opus Genetics stockholders approve doubling authorized shares to 250M at annual meeting","bullets":["Stock increase proposal passed: 45,360,642 for, 1,486,247 against, 429,479 abstentions.","Say-on-pay approved with 34,862,743 votes for, 259,749 against, 110,779 abstentions.","All nine board nominees elected, each receiving over 33.8M votes for.","Ernst & Young ratified as independent auditor for FY 2026.","Meeting held April 20, 2026; all proposals passed."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-015990","json":"https://secwatch.observer/filing/0001140361-26-015990.json","markdown":"https://secwatch.observer/filing/0001140361-26-015990.md","text":"https://secwatch.observer/filing/0001140361-26-015990.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1228627/000114036126015990/0001140361-26-015990-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1228627/000114036126015990/ef20071112_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T04:50:37.116265+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}